VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-a.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-a.
CD56dim CD16- Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-a. Front Immunol. 2019; 10:14.
View in:
PubMed
subject areas
Antigen Presentation
Antigen-Presenting Cells
Biomarkers
Cancer Vaccines
CD56 Antigen
Clinical Trials, Phase I as Topic
Combined Modality Therapy
Cytotoxicity, Immunologic
Humans
Immunophenotyping
Immunotherapy
Interferon-alpha
Killer Cells, Natural
Lymphocyte Activation
Melanoma
Neoplasm Staging
Receptors, IgG
Treatment Outcome
Tumor Microenvironment
authors with profiles
JOHN KIRKWOOD